These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24513041)

  • 1. Synthesis and in vitro anti-proliferative effects of 3-(hetero)aryl substituted 3-[(prop-2-ynyloxy)(thiophen-2-yl)methyl]pyridine derivatives on various cancer cell lines.
    Reddy Chamakura U; Sailaja E; Dulla B; Kalle AM; Bhavani S; Rambabu D; Kapavarapu R; Rao MV; Pal M
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1366-72. PubMed ID: 24513041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New di(hetero)arylethers and di(hetero)arylamines in the thieno[3,2-b]pyridine series: synthesis, growth inhibitory activity on human tumor cell lines and non-tumor cells, effects on cell cycle and on programmed cell death.
    Queiroz MJ; Peixoto D; Calhelha RC; Soares P; Dos Santos T; Lima RT; Campos JF; Abreu RM; Ferreira IC; Vasconcelos MH
    Eur J Med Chem; 2013 Nov; 69():855-62. PubMed ID: 24121236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 2-substituted Furo[3,2-b]pyridines Under Pd/C-Cu Catalysis Assisted by Ultrasound: Their Evaluation as Potential Cytotoxic Agents.
    Laxmi DS; Vardhini SV; Guttikonda VR; Rao MVB; Pal M
    Anticancer Agents Med Chem; 2020; 20(8):932-940. PubMed ID: 32160853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
    Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
    Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity.
    Abdel-Rahman AA; Shaban AKF; Nassar IF; El-Kady DS; Ismail NSM; Mahmoud SF; Awad HM; El-Sayed WA
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34206976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
    Basnet A; Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jahng Y; Na Y; Cho WJ; Kwon Y; Lee CS; Lee ES
    Bioorg Med Chem Lett; 2010 Jan; 20(1):42-7. PubMed ID: 19954977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activity.
    Baviskar AT; Banerjee UC; Gupta M; Singh R; Kumar S; Gupta MK; Kumar S; Raut SK; Khullar M; Singh S; Kumar R
    Bioorg Med Chem; 2013 Sep; 21(18):5782-93. PubMed ID: 23920485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, cytotoxicity and DNA-binding properties of Pd(II), Cu(II) and Zn(II) complexes with 4'-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-2,2':6',2″-terpyridine.
    Chu W; Wang Y; Liu S; Yang X; Wang S; Li S; Zhou G; Qin X; Zhou C; Zhang J
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5187-91. PubMed ID: 23927970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki-Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle.
    Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; Lima RT; Vasconcelos MH
    Eur J Med Chem; 2010 Dec; 45(12):5628-34. PubMed ID: 20926160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies.
    Abreu RM; Ferreira IC; Calhelha RC; Lima RT; Vasconcelos MH; Adega F; Chaves R; Queiroz MJ
    Eur J Med Chem; 2011 Dec; 46(12):5800-6. PubMed ID: 22014996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, single crystal and antitumor activities of benzimidazole-quinazoline hybrids.
    Sharma A; Luxami V; Paul K
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3288-94. PubMed ID: 23611732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, computational quantum chemical study, in silico ADMET and molecular docking analysis, in vitro biological evaluation of a novel sulfur heterocyclic thiophene derivative containing 1,2,3-triazole and pyridine moieties as a potential human topoisomerase IIα inhibiting anticancer agent.
    Murugavel S; Ravikumar C; Jaabil G; Alagusundaram P
    Comput Biol Chem; 2019 Apr; 79():73-82. PubMed ID: 30731361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cytotoxic activity of 5,6-heteroaromatically annulated pyridine-2,4-diamines.
    Willemann C; Grünert R; Bednarski PJ; Troschütz R
    Bioorg Med Chem; 2009 Jul; 17(13):4406-19. PubMed ID: 19481463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
    Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
    Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel 1,2,3-triazole tagged pyrazolo[3,4-b]pyridine derivatives and their cytotoxic activity.
    Kurumurthy C; Veeraswamy B; Sambasiva Rao P; Santhosh Kumar G; Shanthan Rao P; Loka Reddy V; Venkateswara Rao J; Narsaiah B
    Bioorg Med Chem Lett; 2014 Feb; 24(3):746-9. PubMed ID: 24424132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents.
    Eissa IH; El-Naggar AM; El-Hashash MA
    Bioorg Chem; 2016 Aug; 67():43-56. PubMed ID: 27253830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity.
    Dam J; Ismail Z; Kurebwa T; Gangat N; Harmse L; Marques HM; Lemmerer A; Bode ML; de Koning CB
    Eur J Med Chem; 2017 Jan; 126():353-368. PubMed ID: 27907874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents.
    Abuhaie CM; Bîcu E; Rigo B; Gautret P; Belei D; Farce A; Dubois J; Ghinet A
    Bioorg Med Chem Lett; 2013 Jan; 23(1):147-52. PubMed ID: 23200248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols.
    Singh P; Kaur P; Luxami V; Kaur S; Kumar S
    Bioorg Med Chem; 2007 Mar; 15(6):2386-95. PubMed ID: 17275313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.